CoChat

The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease

Cummings, Jeffrey L. · 2000 · The International Journal of Neuropsychopharmacology
Cited by 57

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is characterized by progressive cognitive deterioration, neuropsychological or behavioural disturbances, and eventual elementary neurological dysfunction. Changes in these domains lead to a reduced functional ability of the AD patient which results, inevitably, in an increasing dependency of the patient on their carer. Thus, a compromised quality of life for both the patient with AD and the carer ensues. The clinical deterioration in AD is produced by neurochemical deficits (involving cholinergic, noradrenergic and serotonergic systems) and histological changes (neuritic plaques, neurofibrillary tangles and neuronal death) in the brain. The abnormality in cholinergic neurotransmission, by contributing to both the cognitive impairment and possibly the behavioural disturbances of AD patients, has attracted particularly intense scientific attention. Evidence for the involvement of a cholinergic dimension to the behavioural changes of AD includes the following: the induction of AD-like behaviours in normal individuals by administration of anticholinergic drugs; the exaggeration of behavioural disturbances in AD patients by anticholinergic agents; the correlation of the distribution of cholinergic deficits of AD with regions that are relevant to the observed behaviours, i.e. the frontal and temporal regions; and the amelioration of behavioural disturbances in AD patients treated with cholinergic receptor agonists and cholinesterase inhibitors. This article reviews the increasing evidence that, in addition to their effects on the cognitive and functional domains of AD, cholinergic drugs may be considered psychotropic agents and are useful in the treatment of specific disorders with cholinergic deficits such as AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145700001917

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 57

Metadata

Authors
Cummings, J. L.
Venue
The International Journal of Neuropsychopharmacology
Published
2000-07
Volume
3
Issue
7
Pages
21-29
ISSN
1461-1457 (ISSN-L)
OpenAlex
W1991702492
Cited by
57
References
5
FWCI
1.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease. https://app.cochat.ai/papers/10.1017/s1461145700001917
The paper
Cummings, J. L. (2000). The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145700001917

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.